ClinicalTrials.gg
Active, not recruitingNCT07498192Updated Oct 21, 2026

Thailand Birth and Infant Outcomes Study

An observational study in Outcome Assessment, sponsored by Mead Johnson Nutrition. Active, not recruiting at 1 site in Thailand. Open to participants aged Up to 120 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-21.

Sponsored by Mead Johnson Nutrition (part of Reckitt) · Observational

Updated Oct 21, 2026Now Active, not recruitingFirst site in Thailand+5 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
10,300
Ages
Up to 120 Years
Sex
All
01

Study summary

The goal of this observational study is to examine national trends in mode of delivery and to assess associations between cesarean section and early-life health outcomes using routinely collected health data in Thailand. The study includes mother-infant dyads delivering in public hospitals across Thailand.

The main questions it aims to answer are:

Is cesarean delivery associated with increased risk of adverse neonatal outcomes compared with vaginal delivery?

Is cesarean delivery associated with differences in early-life healthcare utilization and breastfeeding outcomes during the first year of life?

Researchers will compare infants born by cesarean section with infants born by vaginal delivery to evaluate differences in neonatal morbidity, healthcare utilization, and breastfeeding patterns.

Participants will not receive any intervention. The study involves secondary analysis of de-identified national health administrative and clinical data, including delivery records and linked maternal and infant health outcomes.

02

Conditions studied

  • Outcome Assessment
03

In context

Lead sponsor

Mead Johnson Nutrition is the lead sponsor of 58 studies on the registry; 1 is open to participants now.

First submitted after Mead Johnson Nutrition became part of Reckitt.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Up to 120 Years
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

This study includes mother-infant dyads identified retrospectively from routinely collected, de-identified national health administrative and clinical data from public hospitals in Thailand.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Mother-infant dyads with delivery records available in the national health administrative database.
  • Deliveries occurring in public hospitals in Thailand during the study period.
  • Records containing information on mode of delivery and linked maternal and infant outcomes.

Exclusion criteria

Exclusion Criteria:

  • Records with missing or invalid delivery mode information.
  • Records that cannot be reliably linked between mother and infant.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
10,300 participants (estimated)
Patient registry
No

Groups and cohorts

  • Cesarean Delivery Cohort

    Mother-infant dyads in which delivery occurred by cesarean section. This observational cohort is identified retrospectively using routinely collected, de-identified national health data. No intervention is assigned.

  • Vaginal Delivery Cohort

    Mother-infant dyads in which delivery occurred by vaginal birth. This observational cohort is identified retrospectively using routinely collected, de-identified national health data. No intervention is assigned.

06

What researchers measure

Primary outcomes

  1. Neonatal health outcomes associated with mode of delivery

    Comparison of neonatal health outcomes, including birth asphyxia, neonatal infection, respiratory complications, and low birth weight, between infants born by cesarean section and vaginal delivery using routinely collected national health data.

    Time frame: Birth to 28 days of life

Secondary outcomes

  1. Early-life healthcare utilization during infancy

    Frequency of healthcare utilization, including outpatient visits, emergency department visits, hospital admissions, and antibiotic use among infants by mode of delivery.

    Time frame: Birth to 12 months of age

  2. Breastfeeding outcomes by mode of delivery

    Rates of exclusive and any breastfeeding among infants born by cesarean section compared with vaginal delivery, assessed using routinely collected health and nutrition records.

    Time frame: Birth to 12 months of age

  3. Temporal and geographic trends in cesarean delivery rates

    Trends in cesarean section rates across regions, hospital levels, and time periods using national health administrative data.

    Time frame: Jan 2015 to Dec 2025

07

Study locations

1 site
  • Chulaongkorn University
    Bangkok, Thailand
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it moved

Started Apr 2026 (actual). Primary completion is estimated for Dec 2026, 8 months after the start.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 21, 2026: start Mar 2026 → Apr 2026, primary completion May 2026 → Dec 2026 and completion Dec 2026 → Mar 2027.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 23, 2026
First posted
Mar 27, 2026
StartActual
Apr 7, 2026was Mar 2026
Primary completionEst.
Dec 30, 2026was May 2026
CompletionEst.
Mar 30, 2027was Dec 2026
Last update
Oct 21, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Not yet recruiting→Active, not recruiting
changed Oct 21, 2026
Sites
1 site added — first site in Thailand
Show site
  • Chulaongkorn University · Bangkok, Thailand
Oct 21, 2026
Start date
Mar 1, 2026→Apr 7, 2026 (actual)
Oct 21, 2026
Primary completion
May 30, 2026→Dec 30, 2026
Oct 21, 2026
Study completion
Dec 31, 2026→Mar 30, 2027
Oct 21, 2026
Secondary outcomes
1 time frame changed
What changed in the outcomes
  • Time frameTemporal and geographic trends in cesarean delivery rates2015 to 2025 → Jan 2015 to Dec 2025
Oct 21, 2026
Title
Thai Baby Study Phase 1→Thailand Birth and Infant Outcomes Study
Oct 21, 2026
Show all 1 update
  1. Oct 21, 2026
    Not yet recruiting→Active, not recruiting
    1 site added — first site in Thailand
    Show site
    • Chulaongkorn University · Bangkok, Thailand
    Start date Mar 1, 2026→Apr 7, 2026 (now actual)
    Primary completion May 30, 2026→Dec 30, 2026
    Study completion Dec 31, 2026→Mar 30, 2027
    Secondary outcomes 1 time frame changed
    What changed in the outcomes
    • Time frameTemporal and geographic trends in cesarean delivery rates2015 to 2025 → Jan 2015 to Dec 2025
    Title Thai Baby Study Phase 1→Thailand Birth and Infant Outcomes Study
    + 2 other changes: verification date and contact details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07498192
Collaborators
Chulalongkorn University, Ministry of Health, Thailand
Responsible party
Sponsor
First posted
Mar 27, 2026
Start date
Apr 7, 2026
Primary completion
Dec 30, 2026 (estimated)
Completion
Mar 30, 2027 (estimated)
Last update
Oct 21, 2026

Study contacts

Veronica Fabrizio, DO
study director · Mead Johnson Nutrition
Krit Pongpirul, MD, MPH, PhD
principal investigator · Chulalongkorn University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is active, not recruiting, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion